- Types of Eczema
- Child Eczema
- Causes & Triggers
- Living with Eczema
- Eczema Products
- Get Involved
January 9, 2014 – A basic skin care regimen should focus on the fundamental aspects of atopic dermatitis. In atopic dermatitis there’s a skin barrier function problem.
January 9, 2015 – NEA asked this question on Facebook recently: In order for prescription medications to be most effective, a proper bathing and moisturizing regimen is required. What’s your bathing and moisturizing routine?
Here’s what people had to say:
January 6, 2015 – For the first time, a team led by researchers at the Icahn School of Medicine at Mount Sinai has proven that atopic dermatitis, also known as eczema, is an immune-driven (autoimmune) disease.
December 18, 2014 – Twice-weekly proactive maintenance therapy with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis resulted in dramatic improvement in self-reported quality of life in a 12-month observational study.
December 16, 2014 – Archive of Hope for Eczema: New Treatment Developments is now available.
December 15, 2014 – Patients on subcutaneous dupilumab at 300 mg once weekly showed nearly an 80% reduction from baseline in Eczema Area and Severity Index scores after 16 weeks of treatment.
December 15, 2014 – Nickel has long ranked at the top of common contact allergens. In fact, it earned the No. 1 spot in the North American Contact Dermatitis Group patch test results in 2009-2010.
December 8, 2014 – Pediatricians should seek a skin-directed approach to the treatment of atopic dermatitis (AD), according to an updated AAP clinical report that outlines research linking the disease to abnormalities in the skin barrier.
December 1, 2014 – In children with atopic dermatitis, serious superinfections are more likely to be caused by group A beta-hemolytic Streptococcus than methicillin-resistant Staphylococcus aureus.
December 1, 2014 – There is a limited range of treatments for severe atopic dermatitis (AD). Azathioprine has often been used but there has been no randomized controlled trial of this drug to confirm its efficacy in AD.